LIVZON PHARMA (01513) spent 8.7832 million yuan on September 24 to repurchase 250,000 shares of A shares.
Lizhu Pharmaceutical (01513) announced that the company invested 8.7832 million yuan on September 24, 2024...
LIVZON PHARMA (01513) announced that the company spent 8.7832 million yuan to repurchase 250,000 A shares on September 24, 2024. The repurchase price was between 34.95 yuan and 35.76 yuan per share.
Related Articles
MINIEYE has spent over HK$73 million to repurchase shares, showing confidence in long-term development.
SCHOLAR EDU (01769) issues profit warning, expecting the net loss attributable to owners of the company for 2025 to be between 70 million and 80 million yuan, turning from profit to loss year-on-year.
HC ENV TECH (02265) plans to acquire 100% equity of Laizhou Jinxing Chemical Co., Ltd. for RMB 71.17 million.
MINIEYE has spent over HK$73 million to repurchase shares, showing confidence in long-term development.
SCHOLAR EDU (01769) issues profit warning, expecting the net loss attributable to owners of the company for 2025 to be between 70 million and 80 million yuan, turning from profit to loss year-on-year.
HC ENV TECH (02265) plans to acquire 100% equity of Laizhou Jinxing Chemical Co., Ltd. for RMB 71.17 million.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
